Diamond, Jennifer R.
University of Colorado Anschutz · University of Colorado Denver
3 papers on CoChatORCID 0000-0002-0703-2772
Most cited papers
- Verified
Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer
Bardia, A., Mayer, I. A., Vahdat, L. T., Tolaney, S. M., Isakoff, S. J., Diamond, J. R., O’Shaughnessy, J., Moroose, R. L., Santin, A. D., Abramson, V. G., et al. (2019) · New England Journal of Medicine
Breast Cancer Treatment StudiesAdvanced Breast Cancer Therapies
Cited by 874
- Verified
Phase I study of REGN421 (R)/SAR153192, a fully‐human delta‐like ligand 4 (Dll4) monoclonal antibody (mAb), in patients with advanced solid tumors
Jimeno, A., LoRusso, P., Strother, R. M., Diamond, J. R., Plato, L., Younger, A., Messersmith, W. A., Kittaneh, M., Sawyer, D., Adriaens, L., et al. (2013) · Journal of Clinical Oncology
Angiogenesis and VEGF in CancerCancer Immunotherapy and Biomarkers
Cited by 15
- Verified
A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid malignancies and biliary tract cancers
Ma, W. W., Zhu, M., Lam, E. T., Diamond, J. R., Dy, G. K., Fisher, G. A., Goff, L. W., Alberts, S., Bui, L. A., Sanghal, A., et al. (2021) · Cancer Chemotherapy and Pharmacology
Cancer Treatment and PharmacologyNanoparticle-Based Drug Delivery
Cited by 12
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free